| |
| |
|
| Insider
Information: |
Gano Kyle |
| Relationship: |
Chief Business Develop... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,166 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$19,232,770 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,166 |
|
|
| Total
Value |
$19,232,770 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Business Develop... |
2024-02-13 |
135,166 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-01-02 |
4 |
AS |
$131.44 |
$9,860,194 |
D/D |
(75,000) |
130,250 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-01-02 |
4 |
OE |
$19.59 |
$1,469,250 |
D/D |
75,000 |
136,366 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2016-04-11 |
4 |
OE |
$5.76 |
$240,595 |
D/D |
41,770 |
97,633 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2016-04-11 |
4 |
AS |
$43.50 |
$1,838,511 |
D/D |
(41,770) |
55,863 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
See Remarks |
• – – |
2015-06-01 |
4 |
AS |
$42.19 |
$1,612,924 |
D/D |
(38,230) |
26,613 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
See Remarks |
• – – |
2015-06-01 |
4 |
OE |
$2.59 |
$172,655 |
D/D |
38,230 |
64,843 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2018-08-01 |
4 |
OE |
$8.66 |
$244,784 |
D/D |
28,266 |
107,008 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2018-08-01 |
4 |
AS |
$115.00 |
$3,250,590 |
D/D |
(28,266) |
78,742 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2022-01-05 |
4 |
AS |
$85.50 |
$2,416,751 |
D/D |
(28,266) |
104,984 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2022-01-05 |
4 |
OE |
$8.66 |
$244,784 |
D/D |
28,266 |
133,250 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Dev Officer |
• – – |
2015-01-13 |
4 |
OE |
$2.59 |
$96,450 |
D/D |
25,000 |
49,988 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Dev Officer |
• – – |
2015-01-13 |
4 |
AS |
$30.00 |
$750,000 |
D/D |
(25,000) |
24,988 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2015-10-16 |
4 |
AS |
$47.77 |
$1,194,250 |
D/D |
(25,000) |
51,613 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-11-02 |
4 |
AS |
$71.05 |
$1,763,319 |
D/D |
(24,818) |
73,246 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-11-02 |
4 |
OE |
$8.65 |
$214,810 |
D/D |
24,818 |
86,714 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2018-03-05 |
4 |
AS |
$90.00 |
$2,128,500 |
D/D |
(23,650) |
78,742 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2018-03-05 |
4 |
OE |
$8.65 |
$204,573 |
D/D |
23,650 |
102,392 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-09-06 |
4 |
AS |
$60.00 |
$1,223,580 |
D/D |
(20,393) |
73,246 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-09-06 |
4 |
OE |
$8.65 |
$176,399 |
D/D |
20,393 |
93,639 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-05-01 |
4 |
AS |
$54.00 |
$810,000 |
D/D |
(15,000) |
73,246 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-05-01 |
4 |
OE |
$2.59 |
$38,850 |
D/D |
15,000 |
88,246 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2023-02-07 |
4 |
AS |
$102.29 |
$1,476,982 |
D/D |
(14,424) |
127,216 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
73,246 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2022-02-07 |
4 |
AS |
$80.68 |
$476,549 |
D/D |
(5,900) |
110,294 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Dev Officer |
• – – |
2014-12-17 |
4 |
OE |
$5.00 |
$24,785 |
D/D |
4,957 |
28,695 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
